Back to today’s briefing

Story perspectives

Breakthrough Gene Discovery Enhances Cancer Immunotherapy Effectiveness

8/4/2025

26 3

Summary

Story summary

Researchers at the Garvan Institute and UNSW Sydney have uncovered crucial insights into why certain cancer patients thrive on immunotherapy. Their groundbreaking study shows that less active forms of the NOD2 gene, when paired with radiotherapy, can significantly boost immune responses. This discovery paves the way for tailored immunotherapy treatments, offering hope for more effective cancer care.

1 of 1

Story summary

Researchers at the Garvan Institute and UNSW Sydney have uncovered crucial insights into why certain cancer patients thrive on immunotherapy. Their groundbreaking study shows that less active forms of the NOD2 gene, when paired with radiotherapy, can significantly boost immune responses. This discovery paves the way for tailored immunotherapy treatments, offering hope for more effective cancer care.